Loading insider details...
Beta
Latest Form 4 (Sep 24, 2025): Grant/Award of 18,000 MAZE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2025 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 18,000 | n/a |
| Jun 6, 2025 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 136,681 | n/a |
| Jul 2, 2024 | Verve Therapeutics, Inc. (VERV) | Exercise/Conversion | 30,000 | $86.1K |
| Jun 5, 2024 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 102,225 | n/a |
| Feb 16, 2024 | Verve Therapeutics, Inc. (VERV) | Grant/Award | 526,000 | n/a |
| Jun 1, 2023 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 66,055 | n/a |
| Jul 27, 2022 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 71,881 | n/a |